Ricevi le ultime notizie sulle azioni Geovax Labs con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di GOVX

Ultime notizie per

GEOVAX LABS INC

Geovax Labs

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Geovax Labs Inc

Geovax Labs Inc Warrants (01/01/2025)

News

Press Releases

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream

Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream

Small Cap

Opinion

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream

Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream

Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream

Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream

ADVM

AEMD

AIIO

ASBP

ASPI

ATCH

BANL

BENF

BIXT

BNRG

BNZI

CLNN

CSE:HG

CSE:METG

CSE:PHOS

CSE:PMC

CSE:QQQ

CSE:TCEC

CUAUF

CYIO

DERM

EGYF

EHGO

ELRRF

EVFM

FFAI

FRSPF

FUFU

GOVX

GROV

HDRSF

HGRAF

HSCS

IMRFF

IMRN

IPWR

JAGX

KBRIF

KPGHF

KSIOF

LGCXF

MDNAF

MGSTF

NCSM

NTRB

NZAUF

OMEX

ONCY

OPWEF

OSTX

PHXHF

PLAB

PMCCF

PSQH

PUMXF

QQCMF

RGBP

SEVCF

SIGY

SRFM

SRGZ

STKXF

STLNF

STNLF

TCEFF

TIVC

TSX:ELO

TSX:KSI

TSX:MDNA

TSX:ONC

TSX:URE

TSX:VGZ

TSXV:CCCM

TSXV:HI

TSXV:IMR

TSXV:KRI

TSXV:LG

TSXV:OPW

TSXV:PUMA

TSXV:RUA

TSXV:SKP

TSXV:STUD

TSXV:UCU

TSXV:VROY

USEG

UURAF

UXIN

VANI

VROYF

XXII

ZAILF

ZAPPF

ZLAB

Abpro Hldgs

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Aptevo Therapeutics

BioCardia

BioVie

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Curis

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Edesa Biotech

FibroBiologics

Immuron Limited - American Depositary Shares

Immuron

Kairos Pharma

Longeveron

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

MetaVia

OSR Holdings

BiomX

ProMIS Neurosciences Inc. - Common Shares

ProMIS Neurosciences

Propanc Biopharma

Synlogic

Tharimmune

XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty

D. Boral Capital

HC Wainwright & Co.

Alliance Global Partners

EF Hutton

Noble Capital Markets

Comments

Geovax Labs Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO